123 related articles for article (PubMed ID: 23788427)
1. TIF1γ requires sumoylation to exert its repressive activity on TGFβ signaling.
Fattet L; Ay AS; Bonneau B; Jallades L; Mikaelian I; Treilleux I; Gillet G; Hesling C; Rimokh R
J Cell Sci; 2013 Aug; 126(Pt 16):3713-23. PubMed ID: 23788427
[TBL] [Abstract][Full Text] [Related]
2. Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway.
He W; Dorn DC; Erdjument-Bromage H; Tempst P; Moore MA; Massagué J
Cell; 2006 Jun; 125(5):929-41. PubMed ID: 16751102
[TBL] [Abstract][Full Text] [Related]
3. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.
Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H
Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518
[TBL] [Abstract][Full Text] [Related]
4. TIF1γ protein regulates epithelial-mesenchymal transition by operating as a small ubiquitin-like modifier (SUMO) E3 ligase for the transcriptional regulator SnoN1.
Ikeuchi Y; Dadakhujaev S; Chandhoke AS; Huynh MA; Oldenborg A; Ikeuchi M; Deng L; Bennett EJ; Harper JW; Bonni A; Bonni S
J Biol Chem; 2014 Sep; 289(36):25067-78. PubMed ID: 25059663
[TBL] [Abstract][Full Text] [Related]
5. LMO4 can interact with Smad proteins and modulate transforming growth factor-beta signaling in epithelial cells.
Lu Z; Lam KS; Wang N; Xu X; Cortes M; Andersen B
Oncogene; 2006 May; 25(20):2920-30. PubMed ID: 16331278
[TBL] [Abstract][Full Text] [Related]
6. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
[TBL] [Abstract][Full Text] [Related]
7. Tif1γ is essential for the terminal differentiation of mammary alveolar epithelial cells and for lactation through SMAD4 inhibition.
Hesling C; Lopez J; Fattet L; Gonzalo P; Treilleux I; Blanchard D; Losson R; Goffin V; Pigat N; Puisieux A; Mikaelian I; Gillet G; Rimokh R
Development; 2013 Jan; 140(1):167-75. PubMed ID: 23154409
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of TIF1γ by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-β/Smad signaling pathway.
Qi G; Lu G; Yu J; Zhao Y; Wang C; Zhang H; Xia Q
Eur J Pharmacol; 2019 Oct; 860():172551. PubMed ID: 31323225
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.
Johnsen SA; Subramaniam M; Katagiri T; Janknecht R; Spelsberg TC
J Cell Biochem; 2002; 87(2):233-41. PubMed ID: 12244575
[TBL] [Abstract][Full Text] [Related]
10. An Id-like molecule, HHM, is a synexpression group-restricted regulator of TGF-beta signalling.
Ikushima H; Komuro A; Isogaya K; Shinozaki M; Hellman U; Miyazawa K; Miyazono K
EMBO J; 2008 Nov; 27(22):2955-65. PubMed ID: 18923419
[TBL] [Abstract][Full Text] [Related]
11. Role of Smads in TGFβ signaling.
Heldin CH; Moustakas A
Cell Tissue Res; 2012 Jan; 347(1):21-36. PubMed ID: 21643690
[TBL] [Abstract][Full Text] [Related]
12. TGFbeta inducible early gene enhances TGFbeta/Smad-dependent transcriptional responses.
Johnsen SA; Subramaniam M; Janknecht R; Spelsberg TC
Oncogene; 2002 Aug; 21(37):5783-90. PubMed ID: 12173049
[TBL] [Abstract][Full Text] [Related]
13. Recruitment of TIF1γ to chromatin via its PHD finger-bromodomain activates its ubiquitin ligase and transcriptional repressor activities.
Agricola E; Randall RA; Gaarenstroom T; Dupont S; Hill CS
Mol Cell; 2011 Jul; 43(1):85-96. PubMed ID: 21726812
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
15. Novel dominant negative Smad antagonists to TGFbeta signaling.
Ho J; Chen H; Lebrun JJ
Cell Signal; 2007 Jul; 19(7):1565-74. PubMed ID: 17360157
[TBL] [Abstract][Full Text] [Related]
16. miR-629 Targets TRIM33 to Promote TGFβ/Smad Signaling and Metastatic Phenotypes in ccRCC.
Jingushi K; Ueda Y; Kitae K; Hase H; Egawa H; Ohshio I; Kawakami R; Kashiwagi Y; Tsukada Y; Kobayashi T; Nakata W; Fujita K; Uemura M; Nonomura N; Tsujikawa K
Mol Cancer Res; 2015 Mar; 13(3):565-74. PubMed ID: 25381221
[TBL] [Abstract][Full Text] [Related]
17. A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3.
Dennler S; Huet S; Gauthier JM
Oncogene; 1999 Feb; 18(8):1643-8. PubMed ID: 10102636
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin induces the TGFbeta1/Smad signaling cascade in renal mesangial cells upstream of mTOR.
Osman B; Doller A; Akool el-S; Holdener M; Hintermann E; Pfeilschifter J; Eberhardt W
Cell Signal; 2009 Dec; 21(12):1806-17. PubMed ID: 19666112
[TBL] [Abstract][Full Text] [Related]
19. The ubiquitin ligase Smurf2 suppresses TGFβ-induced epithelial-mesenchymal transition in a sumoylation-regulated manner.
Chandhoke AS; Karve K; Dadakhujaev S; Netherton S; Deng L; Bonni S
Cell Death Differ; 2016 May; 23(5):876-88. PubMed ID: 26679521
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic regulation of EMT by TIF1γ and Smad4 in mammary epithelial cells.
Hesling C; Fattet L; Teyre G; Jury D; Gonzalo P; Lopez J; Vanbelle C; Morel AP; Gillet G; Mikaelian I; Rimokh R
EMBO Rep; 2011 Jul; 12(7):665-72. PubMed ID: 21597466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
